- Home
- » Tags
- » Muscarinic antagonist
Top View
- Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
- Ketamine: Differential Neurophysiological Dynamics in Functional Networks in the Rat Brain
- 2021 Equine Prohibited Substances List
- Elective Testing Substances List
- ( 12 ) United States Patent
- The Muscarinic Antagonists Scopolamine and Atropine Are Competitive Antagonists at 5-HT3 Receptors * Martin Lochner A, Andrew J
- Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment Than Scopolamine
- Redalyc.Atropine Is More Efficient Than ZM241385 to Reduce a Drastic
- Role of H3-Receptor-Mediated Signaling in Anxiety and Cognition in Wild-Type and Apoe–/– Mice
- Testing the NMDA, Long-Term Potentiation, and Cholinergic Hypotheses of Spatial Learning
- Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease
- An Approach to Drug Induced Delirium in the Elderly K Alagiakrishnan, C a Wiens
- Combined Β-Adrenergic and Cholinergic Antagonism Produces Behavioral and Cognitive Impairments in the Water Maze
- The Pharmacology of Svt-40776, a New Muscarinic Antagonist for the Treatment of Urinary Incontinence
- Autonomic Nervous System 2 & 3
- Muscarinic Acetylcholine Receptors: Novel Opportunities for Drug Development Andrew C
- Derivatives of 3-Quinuclidinyl Benzilate (Bz)
- Full Prescribing Information for Ventricular Contractions, Flutter, Fibrillation, Etc
- Muscarinic Cholinergic Binding in Rat Brain (Quinuclidinyl Benzilate/Receptors)
- Nicotinic and Muscarinic Agonists and Acetylcholinesterase Inhibitors Stimulate a Common Pathway to Enhance Glun2b-NMDAR Responses
- Antagonism of Muscarinic M1 Receptors by Dicyclomine Inhibits
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- COPD Medications
- FEI EPSL Controlled Medication, 30 November 2018
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- Atropine and Atropine-Like Substances Usable in Warfare
- New Insights Into Drug-Induced Psychosis
- The Muscarinic Antagonist Gallamine Induces Proliferation of Airway
- Effects of Acetylcholine and Cholinergic Antagonists on the Activity of Nucleus of the Solitary Tract Neurons ⇑ Werner I
- Treating 'Devil's Breath' Intoxication: Use of Rivastigmine in Six Patients
- Hallucinogens
- A Review of Common Psychedelic Drugs
- Umeclidinium): a Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
- DUODOTE Safely and Effectively
- Identification of an Ascaris G Protein-Coupled Acetylcholine Receptor with Atypical Muscarinic Pharmacology Michael J
- Stereoselective L-[3H]Quinuclidinyl Benzilate-Binding Sites in Nervous Tissue of Ap/Ysia Californica: Evidence for Muscarinic Receptors’
- Impact of Post-Operative Nausea and Vomiting
- Site-Directed Mutagenesis of the M2 Muscarinic Acetylcholine Receptor
- Known Bioactives Library: Prestwick 2 Collection
- Muscarinic Acetylcholine Receptors in the Retina— Therapeutic Implications
- Rediscovering the Medicinal Properties of Datura Sp.: a Review
- G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Actions
- Muscarinic Receptor)
- WO 2012/112933 Al <
- Anticholinergic Medications and Cognition in Older Adults
- Important Poisonous Plants in Tibetan Ethnomedicine
- Effects of Atropa Belladonna As an Anti-Cholinergic Hemangi Rajput* Essence Natural Health Clinic, Canada
- Atropine Technical Report
- Vertidiz Tablets Are Indicated in Treatment of Vertigo Of
- Exam Experience
- In Vitro and in Vivo Characterization of Cholinergic Receptors in the Rat Heart